U.S. Judge in Texas Invalidates Allergan Patents on Restasis U.S. Judge in Texas Invalidates Allergan Patents on Restasis

A U.S. judge invalidated patents on Allergan Plc ' s dry eye medicine Restasis on the grounds that the patents cover obvious ideas, a decision that drove the pharmaceutical company ' s shares down more than 6%.Reuters Health Information

Source: Medscape Medical News Headlines - October 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news